日企

Nimble Eisai rethinks its game to beat rivals for China's market

The ancient Chinese game of Go requires analytical skills and intuition, and the aim is to enclose territories on the board.

Eisai, Japan's fourth-largest pharmaceutical company, has taken a similar strategy in its approach to the Chinese market, says Pelham Smithers, an independent equities analyst.

“Players of the game Go would recognise Eisai's approach,” says Mr Smithers. “It targets an area, then with a handful of well-placed moves envelops it.”

您已閱讀9%(452字),剩餘91%(4400字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×